| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22K | — |
| R&D Expense | $37.6M | +9.4% |
| SG&A Expense | $26.2M | -0.8% |
| Operating Income | -$68.8M | -12.7% |
| Income Tax | $0 | — |
| Net Income | -$61.4M | -16.4% |
| EPS (Basic) | -$2.73 | +77.3% |
| EPS (Diluted) | -$2.73 | +77.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.4M | -66.0% |
| Current Assets | $23.3M | -60.5% |
| Total Assets | $51.2M | -47.6% |
| Current Liabilities | $14.0M | +6.3% |
| Total Liabilities | $45.6M | -3.1% |
| Stockholders' Equity | $5.6M | -78.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.4M | -4.9% |
| Capital Expenditures | $196K | +653.8% |
| Investing Cash Flow | -$184K | -641.2% |
| Financing Cash Flow | $11.8M | -78.1% |
| Free Cash Flow | -$43.6M | -5.4% |